ข่าวประชาสัมพันธ์ GenScript ProBio+Hibiocy Co

GenScript ProBio Enters Strategic Collaboration with Hibiocy Co. Ltd, the affiliate of Rojukiss International Public Company Limited (KISS) - the leading Thai-based Beauty & Health company, for the development and manufacturing of COVITRAP(TM) and future

GenScript ProBio (a global one-stop CDMO from GenScript Group) today announced a strategic collaboration with Hibiocy Co. Ltd., a private corporation based in Bangkok, Thailand, to accelerate a respiratory-care medical device, COVITRAP(TM) which contains human antibody for Covid-19 inhibiting project. COVITRAP(TM) is a nasal spray which is capable of preventing the Covid-19 virus from attaching to the internal surfaces of the nasal cavity, thus reduces the viral load in the cavity. COVITRAP(TM)